[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fpz5IXkWFoIjOwJS70oPrM2fVXwCpzpbpJG7hW6PAEM4":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":35,"phaseBuckets":36,"rows":43},"Medtronic Cardiac Rhythm and Heart Failure",[4],263,false,11,5,171645,0,259,[14,17,20,22,25,28,30,32],{"name":15,"count":16},"Heart Failure",78,{"name":18,"count":19},"Bradycardia",21,{"name":21,"count":19},"Atrial Fibrillation",{"name":23,"count":24},"Ventricular Fibrillation",10,{"name":26,"count":27},"Arrhythmia",9,{"name":29,"count":27},"Tachycardia",{"name":31,"count":27},"Aortic Valve Stenosis",{"name":33,"count":34},"Chronic Heart Failure",7,[],[37,38,39,40,41,42],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[44,70,96,120],{"intervention":45,"totalTrials":46,"cells":47},"Class I or III Antiarrhythmic Medications",1,{"EARLY_PHASE1":48,"PHASE1":50,"PHASE2":52,"PHASE3":54,"PHASE4":66,"NA":68},{"trials":49,"activeCount":11},[],{"trials":51,"activeCount":11},[],{"trials":53,"activeCount":11},[],{"trials":55,"activeCount":11},[56],{"nctId":57,"briefTitle":58,"status":59,"phases":60,"primaryCompletion":61,"completion":61,"start":62,"enrollment":63,"conditions":64,"interventions":65},"NCT00514735","Tailored Treatment of Permanent Atrial Fibrillation","COMPLETED",[40],"2010-11","2007-05",210,[21],[45],{"trials":67,"activeCount":11},[],{"trials":69,"activeCount":11},[],{"intervention":71,"totalTrials":46,"cells":72},"Flecainide or Sotalol or Propafenone",{"EARLY_PHASE1":73,"PHASE1":75,"PHASE2":77,"PHASE3":79,"PHASE4":92,"NA":94},{"trials":74,"activeCount":11},[],{"trials":76,"activeCount":11},[],{"trials":78,"activeCount":11},[],{"trials":80,"activeCount":11},[81],{"nctId":82,"briefTitle":83,"status":59,"phases":84,"primaryCompletion":85,"completion":86,"start":87,"enrollment":88,"conditions":89,"interventions":91},"NCT00523978","A Clinical Study of the Arctic Front Cryoablation Balloon for the Treatment of Paroxysmal Atrial Fibrillation",[40],"2010-08","2011-07","2006-10",245,[90],"Paroxysmal Atrial Fibrillation",[71],{"trials":93,"activeCount":11},[],{"trials":95,"activeCount":11},[],{"intervention":97,"totalTrials":46,"cells":98},"Diuretics",{"EARLY_PHASE1":99,"PHASE1":101,"PHASE2":103,"PHASE3":114,"PHASE4":116,"NA":118},{"trials":100,"activeCount":11},[],{"trials":102,"activeCount":11},[],{"trials":104,"activeCount":11},[105],{"nctId":106,"briefTitle":107,"status":59,"phases":108,"primaryCompletion":109,"completion":110,"start":111,"enrollment":19,"conditions":112,"interventions":113},"NCT01370564","Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures",[39],"2011-12","2012-01","2011-06",[15],[97],{"trials":115,"activeCount":11},[],{"trials":117,"activeCount":11},[],{"trials":119,"activeCount":11},[],{"intervention":121,"totalTrials":46,"cells":122},"Implantable System for Remodulin",{"EARLY_PHASE1":123,"PHASE1":125,"PHASE2":127,"PHASE3":129,"PHASE4":131,"NA":133},{"trials":124,"activeCount":11},[],{"trials":126,"activeCount":11},[],{"trials":128,"activeCount":11},[],{"trials":130,"activeCount":11},[],{"trials":132,"activeCount":11},[],{"trials":134,"activeCount":11},[135],{"nctId":136,"briefTitle":137,"status":138,"phases":139,"primaryCompletion":140,"completion":140,"start":141,"enrollment":11,"conditions":142,"interventions":144},"NCT03833323","Implantable System for Remodulin Post-Approval Study","WITHDRAWN",[],"2021-06-30","2020-08-01",[143],"Pulmonary Arterial Hypertension",[121]]